Skip to main content
logo
Medicofarma Biotech SA (WSE:MDB)
Poland flag Poland · Delayed Price · Currency is PLN
0.3920
+0.0040 (1.03%)
At close: Aug 14, 2026

Medicofarma Biotech Financials Overview

Millions PLN. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.040.121.220.754.253.34
Revenue Growth
-90.55%-90.21%63.14%-82.34%27.45%-8.59%
Gross Profit
-0.97-1.1-0.26-0.210.530.99
Operating Income
-1.55-1.7-2.07-2.63-1.58-0.28
Net Income
-2.08-2.23-2.3-3.44-1.59-0.22
Earnings Per Share
-0.03-0.03-0.03-0.05-0.02-0.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
000.010.010.510.08
Total Debt
3.913.712.531.39--
Net Cash (Debt)
-3.91-3.71-2.53-1.390.510.08
Net Cash Growth
----556.50%-
Net Cash Per Share
-0.06-0.05-0.04-0.020.010.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.94-0.98-1.020.010.961.82
Capital Expenditures
----1.11-1.21-2.3
Free Cash Flow
-0.94-0.98-1.02-1.1-0.25-0.48
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---21.07%-27.80%12.35%29.64%
Operating Margin
-3529.54%-1418.73%-169.34%-350.57%-37.07%-8.53%
Pretax Margin
-4736.04%-1860.32%-189.68%-486.38%-37.38%-6.45%
Profit Margin
-4736.04%-1860.32%-187.82%-458.07%-37.38%-6.45%
FCF Margin
-2141.71%-820.32%-83.23%-146.38%-5.83%-14.48%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
607.00226.2221.5398.2418.4634.63